Sun Pharma eyes China, Japan mkts
Dilip Shanghvi, MD of India's most valuable drug firm Sun Pharmaceutical Industries and one of the richest first-generation billionaires in the country with a net worth of $7.8 billion, is now looking at...
More than 40% of our long portfolio is in financials, we will not give...
More than 40% of our long portfolio is in financials, we will not give that up easily: Samir Arora
READ SOURCE
Export basket including IT, pharma and metal stocks looks positive: Hemang Jani
Export basket including IT, pharma and metal stocks looks positive: Hemang Jani
READ SOURCE
Oil supply is not a worry because there are multiple sources: MK Surana, HPCL
Oil supply is not a worry because there are multiple sources: MK Surana, HPCL
READ SOURCE
We are not abandoning those stocks that have done well, but looking outside those...
We are not abandoning those stocks that have done well, but looking outside those as well: Sridhar Sivaram
READ SOURCE
Axis Bank, SBI prime contenders for generating alpha; here's why
Axis Bank, SBI prime contenders for generating alpha; here's why
READ SOURCE
Audi plans more than one product every quarter: Audi, India Head
ET Q&A
Balbir Singh Dhillon, who recently took charge as the head of the Audi brand in India, has his plate full to steer the brand out of a sustained decline in a shrinking...
We are not running behind No.1 in volumes; focusing on profitable, sustainable business: Audi...
Balbir Singh Dhillon, who recently took charge as the head of the Audi brand in India, has his plate full to steer the brand out of a sustained decline in a shrinking luxury-car...
Stay with big daddies, avoid poor cousins: Basant Maheshwari
Stay with big daddies, avoid poor cousins: Basant Maheshwari
READ SOURCE
Asset plays can be good options for next decade: Sameer Narayan
Today, if you look at the weightages on the indices, you do not find asset companies, metals or utilities firms, OMCs, nothing. In case inflation was to come back, then most of these...